Our vision is a world of mental wellbeing.
COMPASS is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first programme is researching how investigational COMP360 psilocybin treatment (also known as psilocybin therapy) could help people with treatment-resistant depression.
We want to transform the patient experience in mental health care.
Everyone has a mental health story, be it their own, or that of a friend or loved one. Our people bring their stories, and a wide range of backgrounds and skills to COMPASS.
Our research is evidence-based and underpinned by a commitment to find better ways to support and empower people suffering with poor mental health.
News & views
Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology, and digital platforms.